'Untold Mischief'

Thank you for publishing the Opinion piece by Theodore Rockwell in your March 3, 1997 edition (page 9). Rockwell's elucidation of the (un)scientific basis for United States radiation protection regulations needs to be broadcast from the rooftops. It has caused untold mischief in the regulatory arena, while continuing to propagate the myth that we can have, and can afford, a "risk-free" society. The arguments that, as a society, we must err on the side of "conservative assumptions" have been ca

Written byLeon Swenson
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Thank you for publishing the Opinion piece by Theodore Rockwell in your March 3, 1997 edition (page 9). Rockwell's elucidation of the (un)scientific basis for United States radiation protection regulations needs to be broadcast from the rooftops. It has caused untold mischief in the regulatory arena, while continuing to propagate the myth that we can have, and can afford, a "risk-free" society.

The arguments that, as a society, we must err on the side of "conservative assumptions" have been carried to ridiculous extremes in the application of Linear No-Threshold to regulation of low-level radiation, as Rockwell has so effectively shown. And, as he so eloquently states, when carried to the extremes, "conservative assumptions" may no longer be the "safest" way to go. I fully support his call for revision of present regulations and policies on low-level radiation.

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies